157 related articles for article (PubMed ID: 27379941)
1. The role of microsatellite instability testing in management of colorectal cancer.
Sinicrope FA
Clin Adv Hematol Oncol; 2016 Jul; 14(7):476-9. PubMed ID: 27379941
[No Abstract] [Full Text] [Related]
2. Molecular Evaluation of Colorectal Adenocarcinoma: Current Practice and Emerging Concepts.
Nowak JA; Hornick JL
Surg Pathol Clin; 2016 Sep; 9(3):427-39. PubMed ID: 27523970
[TBL] [Abstract][Full Text] [Related]
3. [DNA mismatch repair and BRAF status in colorectal cancer: Interest for the therapeutic management?].
Cohen R; Cervera P; Svrcek M; Dumont C; Garcia ML; Chibaudel B; de Gramont A; Pocard M; Duval A; Fléjou JF; André T
Bull Cancer; 2015 Jun; 102(6 Suppl 1):S72-81. PubMed ID: 26118880
[TBL] [Abstract][Full Text] [Related]
4. Prognostic and predictive biomarkers in nonmetastatic colorectal cancers.
Haddad FG; Eid R; Kourie HR; Barouky E; Ghosn M
Future Oncol; 2018 Sep; 14(21):2097-2102. PubMed ID: 30101612
[No Abstract] [Full Text] [Related]
5. Distinctive patterns of p53 protein expression and microsatellite instability in human colorectal cancer.
Nyiraneza C; Jouret-Mourin A; Kartheuser A; Camby P; Plomteux O; Detry R; Dahan K; Sempoux C
Hum Pathol; 2011 Dec; 42(12):1897-910. PubMed ID: 21665242
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic and molecular characteristics of synchronous colorectal cancers: heterogeneity of clinical outcome depending on microsatellite instability status of individual tumors.
Bae JM; Cho NY; Kim TY; Kang GH
Dis Colon Rectum; 2012 Feb; 55(2):181-90. PubMed ID: 22228162
[TBL] [Abstract][Full Text] [Related]
7. Similarities of molecular genetic changes in synchronous and metachronous colorectal cancers are limited and related to the cancers' proximities to each other.
Zauber P; Huang J; Sabbath-Solitare M; Marotta S
J Mol Diagn; 2013 Sep; 15(5):652-60. PubMed ID: 23810502
[TBL] [Abstract][Full Text] [Related]
8. Where We Stand With Immunotherapy in Colorectal Cancer: Deficient Mismatch Repair, Proficient Mismatch Repair, and Toxicity Management.
Overman MJ; Ernstoff MS; Morse MA
Am Soc Clin Oncol Educ Book; 2018 May; 38():239-247. PubMed ID: 30231358
[TBL] [Abstract][Full Text] [Related]
9. Microsatellite instability and colorectal cancer.
Geiersbach KB; Samowitz WS
Arch Pathol Lab Med; 2011 Oct; 135(10):1269-77. PubMed ID: 21970482
[TBL] [Abstract][Full Text] [Related]
10. Colorectal Cancer with BRAF D594G Mutation Is Not Associated with Microsatellite Instability or Poor Prognosis.
Amaki-Takao M; Yamaguchi T; Natsume S; Iijima T; Wakaume R; Takahashi K; Matsumoto H; Miyaki M
Oncology; 2016; 91(3):162-70. PubMed ID: 27404270
[TBL] [Abstract][Full Text] [Related]
11. Molecular testing for microsatellite instability and DNA mismatch repair defects in hereditary and sporadic colorectal cancers--ready for prime time?
Søreide K
Tumour Biol; 2007; 28(5):290-300. PubMed ID: 17962726
[TBL] [Abstract][Full Text] [Related]
12. [Pathologic diagnosis of colorectal cancer in the era of personalized therapy].
Lai M
Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):73-6. PubMed ID: 24742564
[No Abstract] [Full Text] [Related]
13. Evaluating the Combination of Microsatellite Instability and Mutation in BRAF as Prognostic Factors for Patients With Colorectal Cancer.
Sinicrope FA
Clin Gastroenterol Hepatol; 2019 Feb; 17(3):391-394. PubMed ID: 29966708
[No Abstract] [Full Text] [Related]
14. A biomarker for metastatic colorectal cancer and treatment goals.
Sudoyo AW
Acta Med Indones; 2014 Apr; 46(2):81-2. PubMed ID: 25053678
[No Abstract] [Full Text] [Related]
15. Role of Deficient Mismatch Repair in the Personalized Management of Colorectal Cancer.
Zhang CM; Lv JF; Gong L; Yu LY; Chen XP; Zhou HH; Fan L
Int J Environ Res Public Health; 2016 Sep; 13(9):. PubMed ID: 27618077
[TBL] [Abstract][Full Text] [Related]
16. Microsatellite instability markers for identifying early-onset colorectal cancers caused by germ-line mutations in DNA mismatch repair genes.
Mead LJ; Jenkins MA; Young J; Royce SG; Smith L; St John DJ; Macrae F; Giles GG; Hopper JL; Southey MC
Clin Cancer Res; 2007 May; 13(10):2865-9. PubMed ID: 17504984
[TBL] [Abstract][Full Text] [Related]
17. Molecular Markers for Colorectal Cancer.
Wright M; Beaty JS; Ternent CA
Surg Clin North Am; 2017 Jun; 97(3):683-701. PubMed ID: 28501255
[TBL] [Abstract][Full Text] [Related]
18. Microsatellite instability in the management of colorectal cancer.
Pino MS; Chung DC
Expert Rev Gastroenterol Hepatol; 2011 Jun; 5(3):385-99. PubMed ID: 21651356
[TBL] [Abstract][Full Text] [Related]
19. Screening for Lynch syndrome and referral to clinical genetics by selective mismatch repair protein immunohistochemistry testing: an audit and cost analysis.
Colling R; Church DN; Carmichael J; Murphy L; East J; Risby P; Kerr R; Chetty R; Wang LM
J Clin Pathol; 2015 Dec; 68(12):1036-9. PubMed ID: 26201544
[TBL] [Abstract][Full Text] [Related]
20. Performance of different microsatellite marker panels for detection of mismatch repair-deficient colorectal tumors.
Xicola RM; Llor X; Pons E; Castells A; Alenda C; Piñol V; Andreu M; Castellví-Bel S; Payá A; Jover R; Bessa X; Girós A; Duque JM; Nicolás-Pérez D; Garcia AM; Rigau J; Gassull MA;
J Natl Cancer Inst; 2007 Feb; 99(3):244-52. PubMed ID: 17284719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
